Black Rock Inc. Bristol Myers Squibb CO Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Black Rock Inc. holds 162,561,081 shares of BMY stock, worth $6.68 Billion. This represents 0.21% of its overall portfolio holdings.
Number of Shares
162,561,081
Previous 168,103,766
3.3%
Holding current value
$6.68 Billion
Previous $8.63 Billion
2.21%
% of portfolio
0.21%
Previous 0.22%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,552Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.65 Billion0.2% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.76 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.65 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.88 Billion0.79% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA53.7MShares$2.21 Billion0.68% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $87.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...